Clinical Trials of Florida, LLC, is a Phase I-IV clinical research site with overnight capabilities and an American Academy of Sleep Medicine State-of-the-Art accredited sleep lab. We focus on respiratory medical research, sleep trials, and endocrinology studies for interventional, observational, and device medical research.

Clinical Trials of Florida, LLC, is directed by Dr. James P. Krainson and Ana T. Marquez, MSF. Both Dr. Krainson and Mrs. Marquez share their passion for conducting clinical trials. They take pride in producing quality data, enforcing a quick turnaround time for the resolution of queries, and require all staff members to obtain their ACRP certification, within two years from employment at Clinical Trials of Florida.

Dr. James P. Krainson, a University of Miami graduate has established himself as one of the “Top Physicians In America”, and is nationally recognized for his expertise in the field of Sleep Medicine. Dr. Krainson also heads a Fellowship Program for Physicians obtaining their training in Sleep Medicine. Additionally, he practices Pulmonary Medicine, and conducts medical research in Sleep, Respiratory, and Endocrinology clinical trials.

Ana T. Marquez, MSF, serves as Research Director for Clinical Trials of Florida, LLC. She has also helped sites across the United States with varying therapeutic indications and Phases, improve their site processes. Furthermore, Mrs. Marquez has been involved in helping clinical research sites with FDA inspections, Sponsor and IRB audits. Mrs. Marquez serves as the Chairman on Drug Information Association’s (DIA) SIAC Committee for Investigative Sites, and also serves as Chairman for the Membership Committee of The Society for Clinical Research Sites (SCRS), a national organization representing the voice of hundreds of sites globally.

Additionally, Mrs. Marquez mentors Research Directors, and new Principal Investigators in their conquest to build superior clinical research facilities, as well as those seeking to improve their existing site processes. She has been praised for her quality control program, her overall knowledge of clinical trial operations, and is recognized amongst sponsors who conduct Phase I-IV pulmonary clinical trials.